REUTERS - Swiss pharmaceutical manufacturer Lonza Group AG on Monday confirmed it is in advanced talks with private equity firm KKR & Co LP to acquire Capsugel, a U.S. maker of capsule products and ...

Xcelience provides the company with specialized clinical trial manufacturing and supply capabilities for a broad range of solid dosage forms Powdersize brings micronization capabilities that augment ...

Private equity firm KKR will buy Pfizer’s Capsugel business for $2.375 billion in cash, the firms revealed Monday morning in a joint statement. Capsugel generated about $750 million in revenue in 2010 ...

Morristown, N.J. – April 28, 2014 – Capsugel today announced an agreement with Chiasma, Inc., wherein Capsugel's Dosage Form Solutions (DFS) business unit is scaling up manufacturing for the only ...

Lonza Group, a Swiss chemicals and biotechnology company, will acquire Capsugel for $5.5 billion, reports Reuters. Here are four things to know about the deal. 1. Capsugel, based in Morristown, N.J., ...

I was going to title this post "Big or Small We Track Them All" but on second thought it seemed too wordy and just a little bit confusing. Pharmaceutical giant Pfizer (PFE) announced today that it is ...

Capsugel adds clinical trial and commercial manufacturing, as well as particle engineering services with two acquisitions. In the latest development in a busy year of mergers and acquisitions in the ...